These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22308038)

  • 1. Crystal structure of human cytochrome P450 2D6 with prinomastat bound.
    Wang A; Savas U; Hsu MH; Stout CD; Johnson EF
    J Biol Chem; 2012 Mar; 287(14):10834-43. PubMed ID: 22308038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of ionic interactions and protein dynamics to cytochrome P450 2D6 (CYP2D6) substrate and inhibitor binding.
    Wang A; Stout CD; Zhang Q; Johnson EF
    J Biol Chem; 2015 Feb; 290(8):5092-5104. PubMed ID: 25555909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of human cytochrome P450 2D6.
    Rowland P; Blaney FE; Smyth MG; Jones JJ; Leydon VR; Oxbrow AK; Lewis CJ; Tennant MG; Modi S; Eggleston DS; Chenery RJ; Bridges AM
    J Biol Chem; 2006 Mar; 281(11):7614-22. PubMed ID: 16352597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of incorporating the 2C5 crystal structure into comparative models of cytochrome P450 2D6.
    Kirton SB; Kemp CA; Tomkinson NP; St-Gallay S; Sutcliffe MJ
    Proteins; 2002 Nov; 49(2):216-31. PubMed ID: 12211002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108.
    de Groot MJ; Vermeulen NP; Kramer JD; van Acker FA; Donné-Op den Kelder GM
    Chem Res Toxicol; 1996; 9(7):1079-91. PubMed ID: 8902262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of model of cytochrome P450 2D6: an in silico tool for predicting metabolism and inhibition.
    Kemp CA; Flanagan JU; van Eldik AJ; Maréchal JD; Wolf CR; Roberts GC; Paine MJ; Sutcliffe MJ
    J Med Chem; 2004 Oct; 47(22):5340-6. PubMed ID: 15481972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of mammalian cytochrome P450 2B4 complexed with 4-(4-chlorophenyl)imidazole at 1.9-A resolution: insight into the range of P450 conformations and the coordination of redox partner binding.
    Scott EE; White MA; He YA; Johnson EF; Stout CD; Halpert JR
    J Biol Chem; 2004 Jun; 279(26):27294-301. PubMed ID: 15100217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism.
    Unwalla RJ; Cross JB; Salaniwal S; Shilling AD; Leung L; Kao J; Humblet C
    J Comput Aided Mol Des; 2010 Mar; 24(3):237-56. PubMed ID: 20361239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A refined substrate model for human cytochrome P450 2D6.
    de Groot MJ; Bijloo GJ; Martens BJ; van Acker FA; Vermeulen NP
    Chem Res Toxicol; 1997 Jan; 10(1):41-8. PubMed ID: 9074801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular modeling-guided site-directed mutagenesis of cytochrome P450 2D6.
    de Graaf C; Oostenbrink C; Keizers PH; van Vugt-Lussenburg BM; van Waterschoot RA; Tschirret-Guth RA; Commandeur JN; Vermeulen NP
    Curr Drug Metab; 2007 Jan; 8(1):59-77. PubMed ID: 17266524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based site of metabolism prediction for cytochrome P450 2D6.
    Moors SL; Vos AM; Cummings MD; Van Vlijmen H; Ceulemans A
    J Med Chem; 2011 Sep; 54(17):6098-105. PubMed ID: 21797232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling species selectivity in rat and human cytochrome P450 2D enzymes.
    Edmund GH; Lewis DF; Howlin BJ
    PLoS One; 2013; 8(5):e63335. PubMed ID: 23691026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of drug metabolism: the case of cytochrome P450 2D6.
    Vermeulen NP
    Curr Top Med Chem; 2003; 3(11):1227-39. PubMed ID: 12769702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of quinidine radically increases the stability and decreases the flexibility of the cytochrome P450 2D6 active site.
    Berka K; Anzenbacherová E; Hendrychová T; Lange R; Mašek V; Anzenbacher P; Otyepka M
    J Inorg Biochem; 2012 May; 110():46-50. PubMed ID: 22459173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated structure- and ligand-based in silico approach to predict inhibition of cytochrome P450 2D6.
    Martiny VY; Carbonell P; Chevillard F; Moroy G; Nicot AB; Vayer P; Villoutreix BO; Miteva MA
    Bioinformatics; 2015 Dec; 31(24):3930-7. PubMed ID: 26315915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme.
    Wang B; Yang LP; Zhang XZ; Huang SQ; Bartlam M; Zhou SF
    Drug Metab Rev; 2009; 41(4):573-643. PubMed ID: 19645588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of CYP2D6 substrate interactions by computational methods.
    Ito Y; Kondo H; Goldfarb PS; Lewis DF
    J Mol Graph Model; 2008 Feb; 26(6):947-56. PubMed ID: 17764997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidation of phenethylamine derivatives by cytochrome P450 2D6: the issue of substrate protonation in binding and catalysis.
    Miller GP; Hanna IH; Nishimura Y; Guengerich FP
    Biochemistry; 2001 Nov; 40(47):14215-23. PubMed ID: 11714275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional and structural characterisation of common cytochrome P450 2D6 allelic variants-roles of Pro34 and Thr107 in catalysis and inhibition.
    Dong AN; Ahemad N; Pan Y; Palanisamy UD; Yiap BC; Ong CE
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Aug; 392(8):1015-1029. PubMed ID: 31025144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary 3D model for cytochrome P450 2D6 constructed by homology model building.
    Koymans LM; Vermeulen NP; Baarslag A; Donné-Op den Kelder GM
    J Comput Aided Mol Des; 1993 Jun; 7(3):281-9. PubMed ID: 8377025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.